Mihail Obrocea, M.D., is a seasoned clinician executive with over 25 years of experience in hematology and oncology across the academic and pharmaceutical sectors. Currently, Mihail serves as the Global Clinical Project Lead in Hematology at AstraZeneca and the CMO/Head of Clinical Development at Type6 Therapeutics, while previously holding significant roles at organizations such as Juno Therapeutics and Pfizer. Mihail's expertise spans cell therapy, immunotherapy, and innovative cancer treatments, underpinned by a strong commitment to advancing drug development to improve patient outcomes. Mihail's academic background includes a Doctor of Medicine degree from Carol Davila University of Medicine and Pharmacy and a Master of Science in Molecular Biology from the University of Ottawa.
This person is not in the org chart
This person is not in any teams
This person is not in any offices